Yongin-si, South Korea

Yo Kyung Chung

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 7.5

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 2013-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: **The Innovative Contributions of Yo Kyung Chung in Enzyme Therapeutics**

Introduction

Yo Kyung Chung is an accomplished inventor based in Yongin-si, South Korea, known for his pioneering work in biochemistry and enzyme therapeutics. With a remarkable portfolio of five patents, Chung has made significant contributions to the understanding and treatment of rare genetic disorders.

Latest Patents

Among his most notable patents is the composition and formulation comprising recombinant human iduronate-2-sulfatase and the preparation method thereof. This groundbreaking invention details a composition featuring recombinant iduronate-2-sulfatase (IDS), along with a method for producing purified recombinant IDS. The unique glycosylation pattern and formylglycine content of Chung's IDS composition differentiate it from existing treatments like ELAPRASE®, providing enhanced pharmaceutical efficacy and increased safety for patients. This innovation holds great potential for the effective therapy of Hunter Syndrome, a serious condition requiring advanced medical solutions.

Career Highlights

Yo Kyung Chung has had a notable career, collaborating with leading organizations in the biotechnology sector. He worked at The Green Cross Corporation and Medigenebio Corporation, companies recognized for their commitment to innovative health solutions and research in enzyme-based therapies. His role in these organizations has allowed him to contribute significantly to the advancement of enzyme therapeutics.

Collaborations

Throughout his career, Chung has collaborated with esteemed colleagues, including Thong-Gyu Jin and Sang Hoon Paik. These collaborations have played a vital role in driving research forward and achieving technological advancements in the field of medical therapies. Working alongside talented individuals has facilitated the exchange of ideas and has been instrumental in the success of his innovations.

Conclusion

Yo Kyung Chung's contributions to biotechnology and enzyme therapeutics are noteworthy and reflect his dedication to improving patient outcomes through innovation. His latest patents not only showcase his inventiveness but also emphasize the importance of collaboration in achieving scientific breakthroughs. As the field of enzyme-based therapies continues to evolve, Chung's work remains a significant part of its advancement, offering hope for those affected by rare genetic disorders.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…